Novel methods

Procedes nouveaux

Abstract

A novel method for treating cardiovascular disease in postmenopausal women is described. Idoxifene is the preferred compound.
L'invention concerne un procédé nouveau, destiné à traiter des maladies cardiovasculaires chez des femmes post-ménopausiques. L'idoxifène est le composé préféré.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (5)

    Publication numberPublication dateAssigneeTitle
    US-4839155-AJune 13, 1989National Research Development CorporationIodotamoxifen derivatives and use for estrogen receptor-positive breast cancer detection and therapy
    US-5470883-ANovember 28, 1995Stromberg; Brent V.Method of treating peripheral vasoconstriction with tamoxifen citrate
    US-5604248-AFebruary 18, 1997Eli Lilly And CompanyMethod for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
    US-5681835-AOctober 28, 1997Glaxo Wellcome Inc.Non-steroidal ligands for the estrogen receptor
    US-5681863-AOctober 28, 1997Merrell Pharmaceuticals Inc.Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors

NO-Patent Citations (1)

    Title
    See also references of EP 0927029A4

Cited By (3)

    Publication numberPublication dateAssigneeTitle
    DE-19905961-A1August 17, 2000Stefan Neubauer, Bruno Allolio, Martin ReinckeUse of estrogens to treat cardiac insufficiency and left ventricular dysfunction following myocardial infarction
    US-6569904-B1May 27, 2003Orion CorporationAgent for lowering endothelin levels
    US-6620806-B2September 16, 2003Pfizer Inc.Methods and kits for improving vascular health